This pilot study will assess the safety and feasibility of using an implantable microdevice to measure local intratumor response to chemotherapy and other clin…

Grade II GliomaGrade III GliomaGrade IV Glioma+5 more

~Estimated

~$10 – $7,500

Oliver JonasNCT04135807

Observational

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Servi…

Brain CancerBrain TumorBrain Neoplasms+9 more

~Estimated

~$10 – $6,250

Dartmouth-Hitchcock Medical CenterNCT06930846

Phase 2

A Phase 2 Trial of All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

This is a Phase II study of the combination of All-Trans Retinonic Acid (ATRA) and PD-1 inhibition (Retifanlimab) in patient with recurrent IDH-mutant glioma. …

GliomaIDH MutationAstrocytoma+1 more

~Estimated

~$10 – $8,750

Stephen Bagley, MD, MSCENCT05345002

← PreviousPage 2 of 2Next →